Paper39199746
Supercritical Fluids: An Innovative Strategy for Drug Development.
Liu H and 4 others. Bioengineering (Basel), 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Supercritical Fluids: An Innovative Strategy for Drug Development. Papers, record 39199746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199746
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023YFB3810000 | Major State Basic R&D Program of China | PubMed | ||
| 81925019 | National Natural Science Foundation of China | PubMed | ||
| 82202330 | National Natural Science Foundation of China | PubMed | ||
| U22A20333 | National Natural Science Foundation of China | PubMed |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32585967 | Drug Release from a Spherical Matrix: Theoretical Analysis for a Finite Dissolution Rate Affected by Geometric Shape of Dispersed Drugs. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32585967 | PubMed |
| 2 | 35469915 | Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate. | Life Sci | 2022 | https://conductscience.org/library/papers/35469915 | PubMed |
| 3 | 21664971 | Iodine-131-lipiodol therapy in hepatic tumours. | Methods | 2011 | https://conductscience.org/library/papers/21664971 | PubMed |
| 4 | 36642250 | Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. | J Control Release | 2023 | https://conductscience.org/library/papers/36642250 | PubMed |
| 5 | 37631243 | Microneedles and Their Application in Transdermal Delivery of Antihypertensive Drugs-A Review. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37631243 | PubMed |
| 6 | 30026127 | Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review. | Adv Drug Deliv Rev | 2018 | https://conductscience.org/library/papers/30026127 | PubMed |
| 7 | 35198072 | A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma. | Theranostics | 2022 | https://conductscience.org/library/papers/35198072 | PubMed |
| 8 | 32553783 | Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32553783 | PubMed |
| 9 | 18597957 | Are pharmaceutics really going supercritical? | Int J Pharm | 2008 | https://conductscience.org/library/papers/18597957 | PubMed |
| 10 | 34716325 | The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation. | Nat Commun | 2021 | https://conductscience.org/library/papers/34716325 | PubMed |
| 11 | 34939176 | A pure nanoICG-based homogeneous lipiodol formulation: toward precise surgical navigation of primary liver cancer after long-term transcatheter arterial embolization. | Eur J Nucl Med Mol Imaging | 2022 | https://conductscience.org/library/papers/34939176 | PubMed |
| 12 | 36144072 | Supercritical Fluids and Nanoparticles in Cancer Therapy. | Micromachines (Basel) | 2022 | https://conductscience.org/library/papers/36144072 | PubMed |
| 13 | 33221371 | Corneal neovascularization. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/33221371 | PubMed |
| 14 | 36659234 | Superstable homogeneous iodinated formulation technology: revolutionizing transcatheter arterial chemoembolization. | Sci Bull (Beijing) | 2020 | https://conductscience.org/library/papers/36659234 | PubMed |
| 15 | 33587385 | 5-Fluorouracil in Dermatology: The Diverse Uses Beyond Malignant and Premalignant Skin Disease. | Dermatol Surg | 2021 | https://conductscience.org/library/papers/33587385 | PubMed |
| 16 | 32302761 | A superstable homogeneous lipiodol-ICG formulation for locoregional hepatocellular carcinoma treatment. | J Control Release | 2020 | https://conductscience.org/library/papers/32302761 | PubMed |
| 17 | 27655376 | Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE-PVE: a comparative study. | Surg Endosc | 2017 | https://conductscience.org/library/papers/27655376 | PubMed |
| 18 | 36915713 | Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways. | Regen Biomater | 2023 | https://conductscience.org/library/papers/36915713 | PubMed |
| 19 | 30561406 | Fluorescence guided surgery in liver tumors: applications and advantages. | Acta Biomed | 2018 | https://conductscience.org/library/papers/30561406 | PubMed |
| 20 | 28681856 | The sounds of nanotechnology. | Nat Nanotechnol | 2017 | https://conductscience.org/library/papers/28681856 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42795049 | Insights on the Generation of Polymeric Drug Carriers via Supercritical Fluid-Assisted Technologies. | Materials (Basel) | 2026 | https://conductscience.org/library/papers/42795049 | PubMed |
| 42270738 | Machine learning-based prediction of paracetamol solubility and CO₂ density in supercritical systems using artificial rabbits optimization. | Sci Rep | 2026 | https://conductscience.org/library/papers/42270738 | PubMed |
| 42198304 | Formulation Strategies to Enhance the Solubility of Poorly Water-Soluble Drugs and Phytochemicals: Current Advances and Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198304 | PubMed |
| 41948173 | Research Progress of Nanodelivery Platforms in the Diagnosis and Treatment of Esophageal Cancer. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41948173 | PubMed |
| 41249332 | Predicting drug solubility in supercritical carbon dioxide green solvent using machine learning models based on thermodynamic properties. | Sci Rep | 2025 | https://conductscience.org/library/papers/41249332 | PubMed |
| 41188833 | Astragaloside IV-loaded zeolitic imidazolate framework-8 based on supercritical fluid as anti-solvent technology to improve bioavailability and anti-tumor activity against non-small cell lung cancer. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41188833 | PubMed |
| 41155665 | Solidification Materials and Technology for Solid Self-Emulsifying Drug Delivery Systems. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155665 | PubMed |
| 40481369 | Nanosizing and Surface Modification by Propellant Assisted Aerosolization Enhances Solubility and Dissolution of Estradiol. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/40481369 | PubMed |
| 40296614 | Advancements and Challenges in Gastroretentive Drug Delivery Systems: A Comprehensive Review of Research Innovation, Technologies, and Clinical Applications. | Recent Adv Drug Deliv Formul | 2026 | https://conductscience.org/library/papers/40296614 | PubMed |
| 39456642 | Optimizing Niclosamide for Cancer Therapy: Improving Bioavailability via Structural Modification and Nanotechnology. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39456642 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39199746
GET https://conductscience.org/api/papers/v1/39199746/references?page=2